XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 4,960 $ 5,130 $ 20,815 $ 10,135
General and administrative 5,021 1,580 12,520 5,081
Total operating expenses 9,981 6,710 33,335 15,216
Loss from operations (9,981) (6,710) (33,335) (15,216)
Other income (expenses):        
Interest income 12 42 42 144
Interest expense 0 13 10 37
Other income (expense) 105 52 (13) 173
Total other income, net 117 81 19 280
Loss before income taxes (9,864) (6,629) (33,316) (14,936)
Income tax benefit 0 0 0 (16)
Loss on investment in joint venture 332 526 1,282 1,009
Net loss and comprehensive loss $ (10,196) $ (7,155) $ (34,598) $ (15,929)
Net loss per common share, basic and diluted $ (0.37) $ (0.32) $ (1.44) $ (1.01)
Weighted average common shares outstanding, basic and diluted 27,527,770 22,142,148 24,011,862 15,772,918